Jorge Arbelbide
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 27
- Acute Myeloid Leukemia Research 15
- Multiple Myeloma Research and Treatments 6
- Chronic Myeloid Leukemia Treatments 5
- Iron Metabolism and Disorders 4
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Dorotea Fantl (8 shared papers)Irma Slavutsky (5 shared papers)Patricia Sorroche (4 shared papers)Laura Boero (4 shared papers)Tomás Meroño (4 shared papers)Fernando Brites (4 shared papers)Carlos G. Musso (1 shared paper)Claudia Corrado (1 shared paper)
In The Last Decade
Jorge Arbelbide
29 papers receiving 249 citations
Peers
Comparison fields: 5 of 58
- Hematology 133
- Genetics 58
- Nephrology 19
- Pharmacology 17
- Clinical Biochemistry 11
Countries citing papers authored by Jorge Arbelbide
This map shows the geographic impact of Jorge Arbelbide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Arbelbide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Arbelbide more than expected).
Fields of papers citing papers by Jorge Arbelbide
This network shows the impact of papers produced by Jorge Arbelbide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Arbelbide. The network helps show where Jorge Arbelbide may publish in the future.
Co-authors
The 25 scholars most cited alongside Jorge Arbelbide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 34 | |
| 2 | 2010 | 31 | |
| 3 | 2017 | 24 | |
| 4 | 2016 | 23 | |
| 5 | 2011 | 22 | |
| 6 | 2013 | 20 | |
| 7 | 2012 | 17 | |
| 8 | 2010 | 16 | |
| 9 | 2009 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 7 | |
| 13 | 2017 | 5 | |
| 14 | 2021 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2015 | 2 | |
| 17 | 2011 | 2 | |
| 18 | 2017 | 2 | |
| 19 | 2019 | 2 | |
| 20 | [Prognostic value of the expression of MDR-1 in acute myeloid leukemia]. | 2003 | 2 |
About Jorge Arbelbide
Jorge Arbelbide is a scholar working on Hematology, Molecular Biology, Genetics, Emergency Medicine and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 252 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Multiple Myeloma Research and Treatments (6 papers), Hematological disorders and diagnostics (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Iron Metabolism and Disorders (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Hematology (133 citations), Genetics (58 citations), Nephrology (19 citations), Pharmacology (17 citations) and Clinical Biochemistry (11 citations). Jorge Arbelbide has collaborated with scholars based in Argentina, Spain and Mexico. Frequent co-authors include Dorotea Fantl, Irma Slavutsky, Patricia Sorroche, Laura Boero, Tomás Meroño, Fernando Brites, Carlos G. Musso, Claudia Corrado, Leonardo Gómez Rosso and Hernán Garcı́a Rivello. Their work appears in journals such as Annals of Hematology, Blood, European Journal of Clinical Investigation, Blood Coagulation & Fibrinolysis and Journal of Clinical Apheresis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.